Uncharted Therapeutics

According to data from the European Organization for Rare Diseases (Eurordis), only 5% of rare diseases have a treatment. Therefore, the search for treatment is another major challenge for anyone interested in starting up a business in this niche.

We need to make it feasible for drug discovery professionals to explore the vast molecular space in their search for new molecules for the development of drugs for rare diseases.

We put in the hands of professionals in the development of therapies for rare diseases, tools to explore the vast molecular space (10^60) still unexplored, in search of new molecules.
We will empower the drug discovery profesionals with generative AI tools to amplify ther intelligence, unleash their creativity and their expertise, removing the roadblocks and burdening of rote and manual work in their day to day activities.

Our goal is to increase the efficiency of R&D, increasing the success rate in pre-clinical and clinical phases, with the quantification and propagation of uncertainty.
But the point is that the algorithm can rely on already patented/known molecules to generate structural modifications on them in order to improve the design criteria, and that these modifications are patentable

Rare diseases is a high-growth therapy area with rapid innovation and significant unmet medical need. Over 7,000 rare diseases are known today, and only c.5% have US Food and Drug Administration-approved treatments1. The global rare disease market is forecasted to grow by a low double-digit percentage in the future.